Sale of Gentronix represents 4.5x return for Northern VCTs
Gentronix – the UK-based contract research organisation (CRO) that is a world leader in genetic toxicology – has been acquired by Scantox Group of Denmark for an undisclosed sum. The deal provides an exit for Mercia Ventures’ Northern Venture Capital Trusts (VCTs), which have sold their stake in the business for £14.8m, representing a 4.5x